After
Candida albicans
,
Candida glabrata
is one of the most common fungal species associated with candidemia in nosocomial infections. Rapid acquisition of nutrients from the host is important for the survival of pathogens which possess the metabolic flexibility to assimilate different carbon and nitrogen compounds. In
Saccharomyces cerevisiae
, nitrogen assimilation is controlled through a mechanism known as Nitrogen Catabolite Repression (NCR). NCR is coordinated by the action of four GATA factors; two positive regulators, Gat1 and Gln3, and two negative regulators, Gzf3 and Dal80. A mechanism in
C. glabrata
similar to NCR in
S. cerevisiae
has not been broadly studied. We previously showed that in
C. glabrata
, Gln3, and not Gat1, has a major role in nitrogen assimilation as opposed to what has been observed in
S. cerevisiae
in which both factors regulate NCR-sensitive genes. Here, we expand the knowledge about the role of Gln3 from
C. glabrata
through the transcriptional analysis of BG14 and
gln3
Δ strains. Approximately, 53.5% of the detected genes were differentially expressed (DEG). From these DEG, amino acid metabolism and ABC transporters were two of the most enriched KEGG categories in our analysis (Up-DEG and Down-DEG, respectively). Furthermore, a positive role of Gln3 in AAA assimilation was described, as was its role in the transcriptional regulation of
ARO8
. Finally, an unexpected negative role of Gln3 in the gene regulation of ABC transporters
CDR1
and
CDR2
and its associated transcriptional regulator
PDR1
was found. This observation was confirmed by a decreased susceptibility of the
gln3
Δ strain to fluconazole.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.